Contract Pharmacal Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CONTRACT PHARMACAL
CONTRACT PHARMACAL has twenty approved drugs.
Summary for Contract Pharmacal
| US Patents: | 0 |
| Tradenames: | 12 |
| Ingredients: | 12 |
| NDAs: | 20 |
Drugs and US Patents for Contract Pharmacal
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Contract Pharmacal | FAMOTIDINE | famotidine | FOR SUSPENSION;ORAL | 219603-001 | Mar 9, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Contract Pharmacal | FEXOFENADINE HYDROCHLORIDE | fexofenadine hydrochloride | TABLET;ORAL | 219032-002 | Feb 28, 2025 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Contract Pharmacal | IBUPROFEN | ibuprofen | TABLET;ORAL | 073691-001 | Feb 25, 1994 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Contract Pharmacal | FAMOTIDINE | famotidine | TABLET;ORAL | 217669-001 | Dec 20, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
